 | Up a level |
Journal Article
Chowdhury, S., Abida, W., Arranz Arija, J., Daugaard, G., Fizazi, K., Gez, E., Heidenreich, A., Joly Lobbedez, F., McDermott, R., Merseburger, A. S., Piulats Rodriguez, J. M., Sautois, B., Sridhar, S., Sternberg, C. N., Watkins, S., Simmons, A., Shetty, S., Golsorkhi, A., Ryan, C. J. and Scher, H. (2017). The TRITON clinical trial programme: Evaluation of the PARP inhibitor rucaparib in patients (Pts) with metastatic castration-resistant prostate cancer (mCRPC) associated with homologous recombination deficiency (HRD). Ann. Oncol., 28. OXFORD: OXFORD UNIV PRESS. ISSN 1569-8041
Hentrich, M., Bower, M., Daugaard, G., Dieing, A., Bickel, M., Berretta, M., Lesmeister, F., Jurinovic, V., Stoehr, A., Heinzelbecker, J., Krznaric, I., Dieckmann, K. -P., Necchi, A., Maroto Rey, P., Rockstroh, J., Pfister, D., Brito, M., Otremba, B. and Hoffmann, C. (2020). Treamtent and outcome of men with HIV-associated germ cell tumors: results from an international collaborative study. Oncol. Res. Treat., 43 (SUPPL 4). S. 126 - 127. BASEL: KARGER. ISSN 2296-5262
Honecker, F., Aparicio, J., Berney, D., Beyer, J., Bokemeyer, C., Cathomas, R., Clarke, N., Cohn-Cedermark, G., Daugaard, G., Dieckmann, K-P., Fizazi, K., Fossa, S., Germa-Lluch, J. R., Giannatempo, P., Gietema, J. A., Gillessen, S., Haugnes, H. S., Heidenreich, A., Hemminki, K., Huddart, R., Jewett, M. A. S., Joly, F., Lauritsen, J., Lorch, A., Necchi, A., Nicolai, N., Oing, C., Oldenburg, J., Ondrus, D., Papachristofilou, A., Powles, T., Sohaib, A., Stahl, O., Tandstad, T., Toner, G. and Horwich, A. (2018). ESMO Consensus Conference on testicular germ cell cancer: diagnosis, treatment and follow-up. Ann. Oncol., 29 (8). S. 1658 - 1687. OXFORD: OXFORD UNIV PRESS. ISSN 1569-8041